Safety and effectiveness of long-term growth hormone therapy in Japanese patients with adult growth hormone deficiency: a postmarketing, multicenter, observational study

Endocrine Journal
Akira ShimatsuKazuo Chihara

Abstract

We aimed to evaluate the long-term safety and effectiveness of growth hormone (GH) therapy in Japanese patients with adult growth hormone deficiency (AGHD). In this observational, multicenter study, Norditropin® (Novo Nordisk A/S, Bagsvaerd, Denmark) was administered as injections of 0.021 mg/kg/week as a starting dose divided into 6-7 doses/week. The dose was increased according to clinical response. Patients' data were obtained from medical records. Measurements (lipids, glucose metabolism, and body composition) taken at baseline; 3, 6, and 12 months; and yearly until the end of the study were collected. Adverse drug reactions (ADRs), serious ADRs, and serious adverse events (SAEs) were evaluated. Of 387 registered patients, 334 were eligible for safety. After GH treatment initiation, a marked decrease in total cholesterol was observed earlier in the child-onset group than in the adult-onset group. LDL-cholesterol also decreased, but no significant differences in changes in LDL-cholesterol between adult-onset and child-onset groups were found. A significant increase in HDL-cholesterol starting 1 year after GH treatment initiation was found in the adult-onset group. There was no effect of GH treatment on glucose metabolism. Be...Continue Reading

References

Aug 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·M RudlingB Angelin
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Apr 5, 2002·The Journal of Clinical Endocrinology and Metabolism·Andrea F AttanasioUNKNOWN Hypoptiuitary Control and Complications Study International Advisory Board
May 8, 2002·The Journal of Clinical Endocrinology and Metabolism·Anne KehelyAndrea F Attanasio
Sep 15, 2004·European Journal of Endocrinology·Kazuo ChiharaAndrea F Attanasio
Oct 7, 2004·Endocrine Reviews·Kin-Chuen LeungKen K Y Ho
Feb 19, 2005·Diabetic Medicine : a Journal of the British Diabetic Association·K WakiUNKNOWN JPHC Study Group
Jul 5, 2005·European Journal of Endocrinology·Kazuo ChiharaAndrea F Attanasio
May 3, 2006·Clinical Endocrinology·Niki KaravitakiJohn A H Wass
May 17, 2006·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·K ChiharaA Shimatsu
Jun 24, 2006·European Journal of Endocrinology·Roger AbsMaria Koltowska-Häggström
Feb 8, 2007·The Journal of Clinical Endocrinology and Metabolism·G GötherströmJ Svensson
Feb 20, 2008·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·K ChiharaA Shimatsu
Apr 9, 2008·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Kazuo ChiharaHitoshi Kohno
Feb 24, 2010·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Kazuo ChiharaKatsuhiko Tachibana
Apr 2, 2010·Journal of Epidemiology·Yasuyuki NakamuraUNKNOWN NIPPON DATA80/90 Research Group
Nov 26, 2010·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Christin SpielhagenHenri Wallaschofski
May 6, 2011·The Journal of Clinical Endocrinology and Metabolism·Andrea F AttanasioUNKNOWN HypoCCS International Advisory Board
Jun 8, 2011·European Journal of Endocrinology·Christopher J ChildUNKNOWN HypoCCS International Advisory Board
Oct 27, 2011·Indian Journal of Endocrinology and Metabolism·Vishal Gupta
Feb 10, 2012·European Journal of Endocrinology·Mariam ElbornssonJohan Svensson
Jan 25, 2013·The Journal of Clinical Endocrinology and Metabolism·Mark L HartmanUNKNOWN International HypoCCS Advisory Board
Feb 23, 2013·European Journal of Endocrinology·Mariam ElbornssonJohan Svensson
Apr 11, 2013·European Journal of Endocrinology·Natasha M Appelman-DijkstraNienke R Biermasz
Feb 7, 2015·The Journal of Clinical Endocrinology and Metabolism·Joseph M PappachanRichard N Clayton
Jun 29, 2015·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Kirstine Stochholm, Gudmundur Johannsson

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.